DiaSorin
€74.90Change from previous close: +1.22%Absolute change: +€0.90
At a glance
- Revenue growth
- +0.81%
- 2025 vs 2024
- Net income growth
- −17.27%
- 2025 vs 2024
- Net margin
- 13.0%
- 2024: 15.9%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total revenue | — | — | — | 306 | 313 |
| Cost of revenue | — | — | — | 104 | 109 |
| Gross profit | — | — | — | 202 | 204 |
| Selling, general and administrative | — | — | — | 81.9 | 103 |
| Research and development | — | — | — | 23.2 | 24.0 |
| Operating income | — | — | — | 74.3 | 74.0 |
| EBIT | — | — | — | 69.2 | 74.0 |
| EBITDA | — | — | — | 69.2 | 74.0 |
| Pre-tax income | — | — | — | 62.4 | 69.0 |
| Income tax | — | — | — | 16.7 | 16.0 |
| Net income | — | — | — | 47.4 | 52.0 |
| Net income to common shareholders | — | — | — | 47.4 | 52.0 |
| Basic EPS | 0.93 | 0.75 | — | 0.85 | 0.96 |
| Diluted EPS | 0.93 | 0.75 | — | 0.85 | 0.96 |
| Average shares (basic) | 49.5 | 50.3 | 53.0 | 53.9 | 53.9 |
| Average shares (diluted) | 49.5 | 50.3 | 53.0 | 53.9 | 53.9 |